AXSM

Axsome Therapeutics (AXSM)

About Axsome Therapeutics (AXSM)

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Details

Daily high

$83.00

Daily low

$75.56

Price at open

$82.00

52 Week High

$105.00

52 Week Low

$64.11

Market cap

4.2B

Dividend yield

0.00%

Volume

2.2M

Avg. volume

509,388

P/E ratio

-13.26

Axsome Therapeutics News